The FDA seems to have been more lenient on who should get the booster dose than the CDC panel. How's is that going to play out?
Unlike the FDA, the CDC panel has not recommended a booster for those at high risk of occupational exposure. Something that an FDA advisory panel unanimously voted to recommend to the FDA. And the FDA obliged.
So we have an FDA approved EUA indication that is not recommended by the CDC panel.
Unless CDC director revises it, I think it will be interesting how this plays out for healthcare workers and teachers.
Unless CDC director revises it, I think it will be interesting how this plays out for healthcare workers and teachers.
Here is the FDA EUA. The third category was voted down by the panel per @nytimes reporting. 
This the CDC panel decision on people at high risk for exposure. @nytimes nytimes.com/live/2021/09/2…
The other issue is that there should have been some risk benefit judgment calls. Now Moderna and J&J recipients are not included.
J&J recipients, 11 million of them, may be rightfully nervous after having received only one dose so far.
J&J recipients, 11 million of them, may be rightfully nervous after having received only one dose so far.
Anticlimax: nbcnews.com/news/us-news/c…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
